Regenerex Pharma Inc.
11/12/2025 | Press release | Distributed by Public on 11/12/2025 14:10
Amendments to Bylaws (Form 8-K)
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On September 22, 2025, the Board of Directors (the "Board") of Regenerex Pharma, Inc. (the "Company") approved a change to the Company's fiscal year end from March 31 to December 31 in accordance with Section 6 of the bylaws of the Company that authorize the Board to change the Company's fiscal year. The Company will file a transition report on Form 10-K for the transition period from April 1, 2025 to December 31, 2025.
Contact: Regenerex Pharma, Inc.
Company Ph: 877-761-RGPX (7479)
Investor Relations Ph: (305) 927-5191
Email: [email protected]
regenerexpharmainc.com
Regenerex Pharma Inc. published this content on November 12, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on November 12, 2025 at 20:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]